Takeda’s fruquintinib recommended by CHMP for metastatic colorectal cancer
Takeda’s fruquintinib has been recommended by the European Medicines Agency’s human medicines committee to treat adults with previously-treated metastatic colorectal cancer (CRC). If granted marketing authorisation by the European Commission (EC), …